Source-grounded facts extracted from HENRY SCHEIN INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
HENRY SCHEIN INC shareholders approved Shareholder proposal to Govern by Majority Vote at the 2026-05-21 meeting.
“The shareholder proposal to Govern by Majority Vote was approved, by non-binding vote, based upon the following votes: For Against Abstain Broker Non-Votes 59,487,608 43,707,406 154,122 5,933,309”
HENRY SCHEIN INC shareholders approved Ratification of the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 26, 2026 at the 2026-05-21 meeting.
“The selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 26, 2026 was ratified based upon the following votes: For Against Abstain 107,298,836 1,805,825 177,784”
HENRY SCHEIN INC shareholders approved Approval, by non-binding vote, of the 2025 compensation paid to the Company’s Named Executive Officers at the 2026-05-21 meeting.
“The 2025 compensation paid to the Company’s Named Executive Officers, commonly known as the “say-on-pay” proposal, was approved, by non-binding vote, based upon the following votes: For Against Abstain Broker Non-Votes 101,159,461 2,110,298 79,377 5,933,309”
HENRY SCHEIN INC shareholders approved Election of ten incumbent directors for terms expiring in 2027 at the 2026-05-21 meeting.
“The ten incumbent directors of the Company were elected to serve for terms expiring in 2027 based upon the following votes: For Against Abstain Broker Non-Votes Mohamad Ali 102,451,460 776,720 120,956 5,933,309 William K. “Dan” Daniel 99,760,754 3,561,487 26,895 5,933,309 Deborah Derby 102,226,374 1,032,737 90,025 5,933,309 Carole T. Faig 103,187,930 106,503 54,703 5,933,309 Kurt P. Kuehn 102,824,264 496,439 28,433 5,933,309 Philip A. Laskawy 97,174,831 6,158,597 15,708 5,933,309 Max Lin 79,900,114 23,411,010 38,012 5,933,309 Frederick M. Lowery 103,001,977 332,786 14,373 5,933,309 Anne H. Margulies 103,199,853 93,763 55,520 5,933,309 Reed V. Tuckson, M.D., FACP 103,198,021 107,489 43,626 5,933,309”
HENRY SCHEIN INC reported fiscal year 2026 results: EPS $5.23 to $5.37 per diluted share. Guidance reaffirmed.
“Henry Schein today reaffirmed its financial guidance for 2026. Guidance is for current continuing operations and does not include the impact of restructuring expenses and related costs, amortization expense of acquired intangible assets, the impairment of intangible assets, changes in contingent consideration, costs associated with shareholder advisory matters, select implementation-related costs supporting value creation initiatives, and litigation settlements. This guidance also assumes that foreign currency exchange rates remain generally consistent with current levels. ● 2026 non-GAAP diluted EPS attributable to Henry Schein, Inc. is unchanged and expected to be $5.23 to $5.37.”
HENRY SCHEIN INC reported the first quarter ended March 28, 2026 results: revenue $3.4 billion, net income $107 million, EPS $0.92 per diluted share.
“First Quarter 2026 Financial Results ● Total net sales for the quarter were $3.4 billion, an increase of 6.3% compared to the first quarter of 2025 and reflects 2.5% internal sales growth, 0.7% sales growth from acquisitions, and a 3.1% increase resulting from foreign currency exchange. First quarter sales growth is detailed in Exhibit A 1. ● Global Distribution and Value-Added Services sales for the quarter increased 6.1%, and reflects 2.5% internal sales growth, 0.6% sales growth from acquisitions, and a 3.0% increase resulting from foreign currency exchange compared with the first quarter of 2025. The main components are: ● Global Dental Distribution merchandise sales for the quarter increased 9.0%, and by 3.0% internal sales growth, compared with the first quarter of 2025, with continuing strong momentum in the U.S. -2- more ● Global Dental Distribution equipment sales for the quarter increased 8.6%, and by 3.5% internal sales growth, compared with the first quarter of 2025. ● Glob”
HENRY SCHEIN INC: Amended and restated By-Laws to eliminate requirement that Board appoint a President and to permit CEO who is not also President or Chairman (effective 2026-01-10).
“On January 10, 2026, upon the recommendation of the Nominating and Governance Committee of the Board, the Board approved an amendment and restatement of the Company’s Fourth Amended and Restated By-Laws (as amended and restated, the “By-Laws”), effective immediately.”
HENRY SCHEIN INC amended Private Shelf Amendments with PGIM, Inc.; NYL Investors LLC; Metropolitan Life Insurance Company; Corebridge Institutional Investors (U.S.), LLC (effective 2025-12-19).
“On December 19, 2025, Henry Schein, Inc. (the “ Company ”) amended its (i) Third Amended and Restated Private Shelf Agreement, dated as of October 20, 2021, by and among the Company, PGIM, Inc. (“ Prudential ”) and each Prudential affiliate party thereto, (ii) Third Amended and Restated Master Note Facility, dated as of October 20, 2021, by and among the Company, NYL Investors LLC (as successor in interest to New York Life Investment Management LLC) (“ New York Life ”) and each New York Life affiliate party thereto, (iii) Third Amended and Restated Master Note Purchase Agreement, dated as of October 20, 2021, by and among the Company, Metropolitan Life Insurance Company (“ MLIC ”), MetLife Investment Management, LLC (as successor in interest to MetLife Investment Advisors Company, LLC) (“ MLIAC ,” and together with MLIC, “ MetLife ”) and each MetLife affiliate party thereto, and (iv) Multicurrency Private Shelf Agreement, dated as of October 20, 2021, by and among the Company, Corebrid”
William K. "Dan" Daniel was appointed as Director at HENRY SCHEIN INC.
“On May 16, 2025, William K. “Dan” Daniel was appointed to the Company’s board of directors (the “ Board ”) as a director.”
Max Lin was appointed as Director at HENRY SCHEIN INC.
“On May 2, 2025, Max Lin was appointed to the Company’s board of directors (the “ Board ”) as a director.”
James P. Breslawski changed role as President at HENRY SCHEIN INC.
“On March 11, 2025, James P. Breslawski, President of Henry Schein, Inc. (the “Company”), informed the Company that effective as of April 1, 2025, he will transition out of the role of President of the Company.”
Robert J. Hombach was appointed as Director at HENRY SCHEIN INC.
“On January 27, 2025, Robert J. Hombach was appointed to the Board as a director.”
HENRY SCHEIN INC reported the first quarter ended March 30, 2024 results: revenue $3.2 billion, net income $93 million, EPS $0.72 per diluted share.
“incident and a strong pipeline of new specialty products and software innovation.” Mr. Bergman added. First-Quarter 2024 Financial Results ● Total net sales for the quarter were $3.2 billion, an increase of 3.7% compared with the first quarter of 2023. Internal sales decreased 1.8% 1 which includes: ● an approximate 300 to 400 basis points decrease in sales from the”
HENRY SCHEIN INC reported financial results for three months and full year ended December 30, 2023.
“On February 27, 2024, Henry Schein, Inc. issued a press release reporting the financial results for the three months and full year ended December 30, 2023.”
Carole T. Faig was appointed as Director at HENRY SCHEIN INC.
“the Board increased the size of the Board to fifteen directors and appointed Carole T. Faig as a new independent director to fill the resulting vacancy, effective immediately.”
HENRY SCHEIN INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“November 13, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because its quarterly report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) would not be filed in a timely manner. The notice and the Company’s response are mandated by Nasdaq and Securities and Exchange Commission (“SEC”) rules. The Rule requires listed companies to timely file all required periodic reports with the SEC”
HENRY SCHEIN INC updated its the third quarter ended September 30, 2023 guidance (reaffirmed).
“On November 13, 2023, Henry Schein, Inc. issued a press release reporting the financial results for the three and nine months, ended September 30, 2023.”
HENRY SCHEIN INC reported the six months ended July 1, 2023 results: revenue $6.2 billion. Guidance reaffirmed.
“solutions, and by revenue cycle management solutions driven by a higher volume of e-claims. Year -to-Date Financial Results ● Total net sales for the first half of 2023 were $6.2 billion, a decrease of 0.8% compared with the first half of 2022. The 0.8% decrease included a 2.0% internal decrease in local currencies, 2.2% growth from acquisitions, and a 1.0%”
HENRY SCHEIN INC reported the second quarter ended July 1, 2023 results: revenue $3.1 billion, net income $140 million, EPS $1.06 per diluted share. Guidance reaffirmed.
“Schein’s leadership in the markets that we serve and to deliver long-term sustainable shareholder value.” Second-Quarter Financial Results ● Total net sales for the quarter were $3.1 billion, an increase of 2.3% compared with the second quarter of 2022. The 2.3% increase included a 0.2% decrease in local currencies excluding acquisitions, 2.9% growth from”
HENRY SCHEIN INC amended revolving credit of $1 billion with JPMorgan Chase Bank, N.A., as administrative agent maturing July 11, 2028.
“On July 11, 2023, the Company amended and restated its existing $1 billion revolving credit agreement, dated as of August 20, 2021, by and among the Company, the several lenders parties thereto, and JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank, N.A., Bank of America, N.A., UniCredit Bank, A.G., the Bank of New York Mellon, ING Bank, N.V. and HSBC Bank USA, N.A., as co-documentation agents (the “ Second Amended and Restated Revolving Credit Agreement ”), to, among other things, (i) extend the termination date to July 11, 2028 and (ii) update the Term Secured Overnight Financing Rate (Term SOFR) provisions to reflect the current market approach for a multicurrency facility.”
HENRY SCHEIN INC incurred term loan of $750 million with JPMorgan Chase Bank, N.A., as administrative agent maturing July 11, 2026.
“On July 11, 2023, Henry Schein, Inc. (the “ Company ”), the several lenders parties thereto, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank, N.A., Bank of America, N.A. and UniCredit Bank, A.G., as co-documentation agents, entered into a new $750 million credit agreement (the “ Term Loan Credit Agreement ”). This new facility, which matures July 11, 2026, is unsecured and is comprised of a $750 million term facility.”
HENRY SCHEIN INC amended Second Amended and Restated Revolving Credit Agreement with the several lenders parties thereto, and JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank, N.A., Bank of America, N.A., UniCredit Bank, A.G., the Bank of New York Mellon, ING Bank, N.V. and HSBC Bank USA, N.A., as co-documentation valued at $1 billion (effective 2023-07-11).
“On July 11, 2023, the Company amended and restated its existing $1 billion revolving credit agreement, dated as of August 20, 2021, by and among the Company, the several lenders parties thereto, and JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank, N.A., Bank of America, N.A., UniCredit Bank, A.G., the Bank of New York Mellon, ING Bank, N.V. and HSBC Bank USA, N.A., as co-documentation agents (the “ Second Amended and Restated Revolving Credit Agreement ”)”
HENRY SCHEIN INC entered into Term Loan Credit Agreement with the several lenders parties thereto, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank, N.A., Bank of America, N.A. and UniCredit Bank, A.G., as co-documentation agents valued at $750 million (effective 2023-07-11).
“On July 11, 2023, Henry Schein, Inc. (the “ Company ”), the several lenders parties thereto, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, and TD Bank, N.A., Bank of America, N.A. and UniCredit Bank, A.G., as co-documentation agents, entered into a new $750 million credit agreement (the “ Term Loan Credit Agreement ”).”
HENRY SCHEIN INC shareholders approved Ratification of BDO USA, LLP as independent auditor at the 2023-12-30 meeting.
“The appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 30, 2023 was ratified based upon the following votes: For Against Abstain 113,558,999 7,958,012 220,474”
HENRY SCHEIN INC shareholders approved Advisory vote on frequency of future say-on-pay votes.
“The proposal to recommend, by non-binding vote, the frequency of future advisory votes on executive compensation, commonly known as the “frequency of say-on-pay” proposal, was approved, by non-binding vote, based upon the following votes: 1 Year 2 Years 3 Years Abstain 113,088,221 77,382 2,183,444 194,131”
HENRY SCHEIN INC shareholders approved Advisory vote on 2022 executive compensation.
“The 2022 compensation paid to the Company’s Named Executive Officers, commonly known as the “say-on-pay” proposal, was approved, by non-binding vote, based upon the following votes: For Against Abstain Broker Non-Votes 105,466,991 9,818,876 257,311 6,194,307”
HENRY SCHEIN INC shareholders approved Amendment and restatement of 2015 Non-Employee Director Stock Incentive Plan (2023 Plan).
“The amendment and restatement of the Company’s 2015 Non-Employee Director Stock Incentive Plan (to be renamed the 2023 Non-Employee Director Stock Incentive Plan) was approved based upon the following votes: For Against Abstain Broker Non-Votes 107,505,366 6,899,730 1,138,082 6,194,307”
HENRY SCHEIN INC shareholders approved Election of fourteen directors for terms expiring in 2024.
“The fourteen directors of the Company were elected to serve for terms expiring in 2024 based upon the following votes: For Against Abstain Broker Non-Votes Mohamad Ali 114,216,459 933,148 393,571 6,194,307 Stanley M. Bergman 105,966,871 9,152,237 424,070 6,194,307 James P. Breslawski 113,265,481 2,154,600 123,097 6,194,307 Deborah Derby 106,463,038 8,953,013 127,127 6,194,307 Joseph L. Herring 112,869,861 2,536,152 137,165 6,194,307 Kurt P. Kuehn 112,275,848 3,135,707 131,623 6,194,307 Philip A. Laskawy 81,948,666 33,453,439 141,073 6,194,307 Anne H. Margulies 114,072,137 1,335,495 135,546 6,194,307 Mark E. Mlotek 113,245,277 2,168,870 129,031 6,194,307 Steven Paladino 111,836,161 3,583,373 123,644 6,194,307 Carol Raphael 113,874,718 1,274,761 393,699 6,194,307 Scott Serota 114,490,393 893,554 159,231 6,194,307 Bradley T. Sheares, Ph.D. 103,836,640 11,558,477 148,061 6,194,307 Reed V. Tuckson, M.D., FACP 114,239,925 917,717 385,536 6,194,307”
HENRY SCHEIN INC reported full-year 2023 results: EPS $5.18 to $5.35. Guidance lowered.
“Updating full-year 2023 non-GAAP diluted EPS guidance to $5.18 to $5.35, reflecting an estimated $0.05 to $0.10 first year dilution from the Biotech Dental acquisition”
HENRY SCHEIN INC reported the first quarter ended April 1, 2023 results: revenue $3.1 billion, net income $121 million, EPS $0.91.
“2 exhibit991.htm PRESS RELEASE MAY 9, 2023 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS ● First-quarter 2023 net sales of $3.1 billion decreased 3.8% compared with first-quarter 2022; internal sales increased 6.3% in local currencies excluding sales of personal protective equipment (PPE) products and COVID-19”
HENRY SCHEIN INC: Amended and restated the Third Amended and Restated By-Laws to update advance notice provisions, universal proxy rules, and other procedures (effective 2023-03-23).
“On March 23, 2023, the Board of Directors (the “Board”) of Henry Schein, Inc. (the “Company”) amended and restated the Company’s Third Amended and Restated By-Laws (as amended and restated, the “By-Laws”), effective immediately.”
HENRY SCHEIN INC reported the three months and full year ended December 31, 2022 results: revenue $3.4 billion, net income $46.8 million, or $0.34 per diluted share, EPS $0.34. Guidance initiated.
“-1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FOURTH-QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS AND INTRODUCES 2023 FINANCIAL GUIDANCE ● Fourth-quarter net sales of $3.4 billion increased 1.2% compared with the fourth quarter of 2021; internal sales increased 5.0% in local currencies when excluding sales of personal protective equipment (PPE) products”
HENRY SCHEIN INC reported the nine months ended September 24, 2022 results: revenue $9.3 billion, net income $491 million, EPS $3.55. Guidance reaffirmed.
“Total net sales for the first nine months of 2022 were $9.3 billion, an increase of 2.3% compared with the first nine months of 2021. The 2.3% increase included 2.4% internal growth in local currencies excluding acquisitions and 2.1% growth from acquisitions, offset by a 2.2% decrease related to foreign currency exchange. Sales of PPE and COVID-19 test kits for the first nine months were $991 million, which is $344 million lower than in the prior-year period. When excluding sales of PPE and COVID-19 test kits, our internal sales growth for the first nine months of 2022 in local currencies was 7.3% compared with the prior-year period. ● GAAP net income for the first nine months of 2022 was $491 million, or $3.55 per diluted share, compared with GAAP net income for the first nine months of 2021 of $484 million, or $3.40 per diluted share.”
HENRY SCHEIN INC reported the three months ended September 24, 2022 results: revenue $3.1 billion, net income $150 million, EPS $1.09. Guidance reaffirmed.
“Total net sales for the quarter were $3.1 billion, a decrease of 3.5% compared with the third quarter of 2021. The 3.5% decrease included a 2.4% decrease in local currencies excluding acquisitions, 1.8% growth from acquisitions and a 2.9% decrease related to foreign currency exchange 1 . Sales of PPE and COVID-19 test kits in the third quarter were $244 million, which is $260 million lower than the prior-year period. When excluding sales of PPE and COVID-19 test kits, our third-quarter internal sales growth in local currencies was 6.8% compared with the prior- year period. ● GAAP net income for the quarter was $150 million, or $1.09 per diluted share, compared with third-quarter 2021 GAAP net income of $162 million, or $1.15 per diluted share.”
Michael S. Ettinger was appointed as Executive Vice President and Chief Operating Officer at HENRY SCHEIN INC.
“On March 30, 2022, the Board of Directors appointed Michael S. Ettinger, 61, as Executive Vice President and Chief Operating Officer, effective upon Mr. Benjamin’s retirement on July 1, 2022.”
Gerald A. Benjamin departed as Executive Vice President and Chief Administrative Officer at HENRY SCHEIN INC.
“On April 4, 2022, Henry Schein, Inc. (the “Company”) announced that Gerald A. Benjamin will retire as Executive Vice President and Chief Administrative Officer of the Company, effective July 1, 2022”
Olga Timoshkina was appointed as Vice President, Corporate Finance and Chief Accounting Officer at HENRY SCHEIN INC.
“Olga Timoshkina, who joined the Company this past September as Vice President, Corporate Controller, will succeed Mr. South as Vice President, Corporate Finance and Chief Accounting Officer, reporting to Mr. South.”
Ronald N. South was appointed as Senior Vice President and Chief Financial Officer at HENRY SCHEIN INC.
“the Company’s Board of Directors appointed Ronald N. South, 60, to succeed Mr. Paladino as Senior Vice President and Chief Financial Officer of the Company, effective upon Mr. Paladino’s retirement on April 29, 2022”
Steven Paladino departed as Executive Vice President and Chief Financial Officer at HENRY SCHEIN INC.
“Steven Paladino will retire as Executive Vice President and Chief Financial Officer of the Company, effective April 29, 2022.”
Barry J. Alperin departed as director at HENRY SCHEIN INC.
“On December 8, 2021, Henry Schein, Inc. (the “Company”) announced that Barry J. Alperin intends to retire from the board of directors of the Company (the “Board”) at the end of his current term and not stand for re-election to the Board at the Company’s 2022 Annual Meeting of Stockholders (the “Annual Meeting”).”
Scott Serota was appointed as director at HENRY SCHEIN INC.
“On December 7, 2021, upon the recommendation of the Nominating and Governance Committee, the Board appointed Scott Serota as a director of the Company, effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.